Correlation Between Eargo, and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eargo, and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eargo, and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eargo, Inc and Neuropace, you can compare the effects of market volatilities on Eargo, and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eargo, with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eargo, and Neuropace.

Diversification Opportunities for Eargo, and Neuropace

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eargo, and Neuropace is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Eargo, Inc and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Eargo, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eargo, Inc are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Eargo, i.e., Eargo, and Neuropace go up and down completely randomly.

Pair Corralation between Eargo, and Neuropace

Considering the 90-day investment horizon Eargo, Inc is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Eargo, Inc is 1.1 times less risky than Neuropace. The stock trades about -0.11 of its potential returns per unit of risk. The Neuropace is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  164.00  in Neuropace on September 6, 2024 and sell it today you would earn a total of  955.00  from holding Neuropace or generate 582.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy30.3%
ValuesDaily Returns

Eargo, Inc  vs.  Neuropace

 Performance 
       Timeline  
Eargo, Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eargo, Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Eargo, is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Neuropace 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Eargo, and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eargo, and Neuropace

The main advantage of trading using opposite Eargo, and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eargo, position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Eargo, Inc and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios